Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07227038

Living Well With Advanced Breast Cancer

This study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they still need.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Advanced Breast Carcinoma Anatomic Stage IV Breast Cancer AJCC v8 Breast Diseases Breast Neoplasms Metastatic Breast Carcinoma Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

Location status: Recruiting

Location contact

Ashley P. Davenport, MD

CONTACT

[email protected]

614-366-8541

Ashley P. Davenport, MD

PRINCIPAL_INVESTIGATOR

About this study

PRIMARY OBJECTIVES:

I. Assess acceptability of current LWABC model. II. Conduct a comprehensive review of participants' medical history, treatment records, and demographic data.

III. Explore differences in survivorship care engagement across four distinct cohorts.

OUTLINE: This is an observational study.

Participants complete a survey and a semi-structured interview on study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • * COHORT 1:
  • Diagnosis of stage 4 metastatic breast cancer within the past 5 years
  • Never been referred to the LWABC
  • Adults age ≥ 18 years
  • COHORT 2:
  • Diagnosis of stage 4 metastatic breast cancer within the past 5 years
  • Have cancelled an appointment with the LWABC
  • Adults age ≥ 18 years
  • COHORT 3:
  • Been seen in the Medical Oncology Clinic at Stephanie Spielman Comprehensive Breast Center (SSCBC) within the past 5 years
  • Completed an appointment with the LWABC
  • Adults age ≥ 18 years
  • COHORT 4:
  • Caregivers for ABC patients
  • Adults age ≥ 18 years

Exclusion criteria

  • Patients who cannot provide own informed consent

Treatment and study plan

Non-Interventional Study

Other

Non-interventional study

Other names: Non-Interventional Observational Study, Noninterventional (Observational) Study

Primary outcomes

  1. Acceptability of current LWABC (Living Well with Advanced Breast Cancer) model

    Time frame: Up to study completion, up to 1 day

    Will utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Survey items will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

  2. Participant medical history, treatment records, and demographic data

    Time frame: Up to study completion, up to 1 day

    Will utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Survey items including demographic information and disease characteristics will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

  3. Differences in survivorship care engagement across four distinct cohorts

    Time frame: Up to study completion, up to 1 day

    Will utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Themes will be compared across each cohort to identify survivorship care needs that will be translated into intervention components for the ABC survivorship program. Survey items will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

Study contacts

Contact information is provided by the study sponsor or research team.

The Ohio State University Comprehensive Cancer Center

CONTACT

[email protected]

800-293-5066

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Collaborators

  • Lilly Foundation

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Nov 12, 2025
Registry last updated
Mar 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.